Home › NDC Lookup › RxCUI directory › RxCUI 313567

Valrubicin 40 MG/ML Intravesical Solution — RxCUI 313567

Name: Valrubicin 40 MG/ML Intravesical Solution (RxCUI 313567)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 313567 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313567

Official nameValrubicin 40 MG/ML Intravesical Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asvalrubicin 200 MG per 5 ML Intravesical Solution; valrubicin 200 MG in 5 mL (40 MG/mL) Intravesical Solution

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Valrubicin Intravesical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Valrubicin is a chemotherapy solution that gets delivered directly into your bladder through a thin tube called a catheter. Once inside, it soaks into the bladder wall and attacks...
What exactly is this drug doing inside my bladder?
Most people feel some bladder irritation — urgency, frequency, burning with urination, or mild blood in the urine. These usually start during or just after the instillation and ten...
What side effects should I expect, and which ones should make me call my doctor?

📖 Read our full Valrubicin Intravesical guide →

🕸️ Concept Web — How Valrubicin 40 MG/ML Intravesical Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Valrubicin 40 MG/ML Intravesical Solution RxCUI 313567 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Valrubicin 31435 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Valstar 220725 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Valrubicin Intravesical Solution 2719347 SCDF
- Valrubicin Intravesical Product 2719346 SCDG
- Valrubicin Intravesical Solution [Valstar] 2719350 SBDF
- Valstar Intravesical Product 2719349 SBDG
- Intravesical Solution 2719932 DF
- Intravesical Product 2718824 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Valrubicin 40 MG/ML 343106 SCDC
- Valrubicin 40 MG/ML Intravesical Solution [Valstar] 262063 SBD
- Valrubicin 40 MG/ML [Valstar] 574649 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Valrubicin 40 MG/ML SCDC · 343106
Valrubicin Intravesical Solution SCDF · 2719347
Valrubicin Intravesical Product SCDG · 2719346

Brand-Name Concepts

Valrubicin 40 MG/ML Intravesical Solution [Valstar] SBD · 262063
Valrubicin 40 MG/ML [Valstar] SBDC · 574649
Valrubicin Intravesical Solution [Valstar] SBDF · 2719350
Valstar Intravesical Product SBDG · 2719349
Valstar BN · 220725

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 313567 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
24201-0101-04	4 VIAL in 1 CARTON (24201-101-04) / 5 mL in 1 VIAL	Valrubicin Intravesical Solution	Hikma Pharmaceuticals USA Inc.	2019-04-23
67979-0001-01	4 VIAL in 1 CARTON (67979-001-01) / 5 mL in 1 VIAL	Valstar	Endo USA, Inc.	1998-10-01

Observed labelers: Endo USA, Inc. (1) · Hikma Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9357	Valrubicin injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.